×
0.000556328233657747 0.000556328233657747 0.0030598052851182 0.00250347705146026 -0.000278164116828874 0 0.000278164116828874 0.000278164116828874
Stockreport

Glancy Prongay & Murray LLP Commences Investigation on Behalf of Halozyme Therapeutics, Inc. Investors (HALO)

HALOZYME THERAPEUTICS (HALO)  More Company Research Source: Business Wire
Last halozyme therapeutics earnings: 5/10 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: halozyme.com/investors/default.aspx
PDF LOS ANGELES--(BUSINESS WIRE)-- Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Halozyme Therapeutics, Inc. (“Halozyme” or the “Company”) (NASDAQ: HALO) investors concerning the Company and its officers’ possible violations of federal securities laws. To obtain information or aid in the investigation, please visit the Halozyme investigation page on our website at www.glancylaw.com/case/halozyme-therapeutics-inc. On January 16, 2018, an abstract was published detailing a study of Halozyme’s drug PEGPH20 as a treatment for pancreatic cancer in combination with the cancer drug mFFOX. The abstract’s authors concluded that the addition of PEGPH20 to mFFOX appears to be detrimental, noting that patients who used the combination experienced higher levels of diarrhea, fatigue, nausea, and vomiting. On this news, Halozyme’s share price fell $1.76, or nearly 9%, to close at $17.98 o [Read more]

IMPACT SNAPSHOT EVENT TIME: HALO
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS